HCP Live

Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy : Episode 5

Available Resources for Narcolepsy Treatment

May 3, 2023

Michael J. Thorpy, MD
Thomas Scammell, MD

Debra Stultz, MD, provides an overview of the available resources that are available for narcolepsy treatment.

EP: 1.Narcolepsy Overview

EP: 2.Burden and Risk Factor of Narcolepsy

EP: 3.Diagnosis of Narcolepsy

EP: 4.EDS Evaluation

EP: 5.Available Resources for Narcolepsy Treatment

EP: 6.Goals of Therapy for Narcolepsy

EP: 7.Pharmacological Treatment Options for Narcolepsy

EP: 8.EDS and Narcolepsy Treatment Options

EP: 9.Pitolisant: Mechanism of Action

EP: 10.Pitolisant Efficacy and Safety

EP: 11.Solriamfetol Efficacy and Safety

EP: 12.Sodium Oxybate and Antidepressants for Treatment of Cataplexy

EP: 13.Unmet Needs in Narcolepsy and Clinical Pearls

Related Videos

Related Content

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Related Content

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.